Sarasin & Partners’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$173M Sell
256,996
-9,876
-4% -$5.87M 1.94% 19
2026
Q2
$134M Buy
266,872
+17,018
+7% +$8.17M 1.57% 22
2026
Q1
$123M Sell
249,854
-14,675
-6% -$7.96M 1.5% 24
2025
Q4
$153M Sell
264,529
-3,878
-1% -$2.19M 1.59% 25
2025
Q3
$124M Buy
268,407
+11,818
+5% +$5.5M 1.22% 28
2025
Q2
$104M Sell
256,589
-119,485
-32% -$50M 1.04% 33
2025
Q1
$187M Buy
+376,074
New +$204M 2.03% 23
2024
Q4
– Sell
-488,325
Closed -$302M – 74
2024
Q3
$302M Sell
488,325
-71,851
-13% -$42.5M 2.85% 17
2024
Q2
$310M Buy
560,176
+100,383
+22% +$57.5M 2.74% 15
2024
Q1
$267M Buy
459,793
+43,678
+10% +$24.5M 2.63% 15
2023
Q4
$221M Buy
416,115
+50,372
+14% +$24.4M 2.43% 15
2023
Q3
$185M Buy
365,743
+8,570
+2% +$4.57M 2.31% 17
2023
Q2
$186M Buy
357,173
+114,497
+47% +$61.8M 2.16% 18
2023
Q1
$140M Sell
242,676
-64,547
-21% -$36.4M 1.76% 23
2022
Q4
$169M Buy
307,223
+29,865
+11% +$15.8M 2.22% 17
2022
Q3
$141M Buy
277,358
+16,490
+6% +$9.23M 1.95% 19
2022
Q2
$142M Buy
260,868
+125,631
+93% +$69.2M 1.79% 23
2022
Q1
$79.9M Buy
+135,237
New +$77.7M 0.8% 39

Other funds holding TMO

Sarasin & Partners's TMO Position: Q3 2026 in Review

Sarasin & Partners reduced its Thermo Fisher Scientific (TMO) stake by 3.7% in Q3 2026, selling an estimated $5.87M and leaving 256,996 shares worth $173M. The position accounts for 1.94% of the portfolio, ranked #19.

Sarasin & Partners first reported a position in TMO in Q1 2022 and has held it in 18 quarters since. The position peaked at $310M in Q2 2024. 2,772 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Sarasin & Partners held 256,996 shares of Thermo Fisher Scientific worth $173M as of Q3 2026.
  • Sarasin & Partners sold 9,876 Thermo Fisher Scientific shares in Q3 2026, an estimated $5.87M.
  • Thermo Fisher Scientific made up 1.94% of Sarasin & Partners's portfolio in Q3 2026, its #19 holding.
  • Sarasin & Partners first reported a position in Thermo Fisher Scientific in Q1 2022 and has held it in 18 quarters since.
  • Sarasin & Partners's Thermo Fisher Scientific position peaked at $310M in Q2 2024.
  • 2,772 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Sarasin & Partners's 13F filing for Q3 2026, filed 13 Oct 2026.